The size of the Europe Platelet Aggregation Devices Market is valued at USD 74.74 million in 2022. It is expected to grow at a CAGR of 22.3% to reach USD 204.49 million by 2027.
An increasing number of industry-academic collaborations and clinical studies and surging advancements in technologies related to platelet aggregation devices are responsible for the market growth. Growing awareness in healthcare professionals regarding the advantages of platelet aggregation testing in diagnosing the disease, frequent increase in orthopedic, urology, and bleeding disorders provide tremendous opportunities leading to escalation of market growth in the region and augmenting occurrence rate of aimed diseases like dengue, HIV, growing demand for Point-of-Care, key players with advanced technologies in platelet aggregometer product anticipated to produce profitable growth in the market. A growing number of surgical processes, increasing approval for platelet treatment in cancer patients, continuous developments in platelet aggregometer integrated with regular chronic diseases, and rising old age people in Europe are leveling up the European platelet aggregation demand devices market.
Strict regulatory policies and restricted medical reimbursements are hampering the platelet aggregation devices market growth in the region. A shortage of well-trained, experienced, and expert professionals are about to obstruct the market. Moreover, adverse healthcare reforms and procedural limitations are restricting the market in this region.
This research report on the Europe Platelet Aggregation Devices Market has been segmented and sub-segmented into the following categories:
Europe holds the second largest market share next to North America. It is due to the availability of affordable platelet function tests and developing distribution channels.
Europe is following North America is leading the market and is accounted to hold the second-largest market share in terms of profits share. The market share is attributed to factors like inexpensive platelet function tests and enhancing distribution channels. The existence of leading manufacturers in the platelet aggregation devices market, a considerable number of people affected with heart-related diseases, neoplasms, and strokes are some factors propelling the growth of the platelet aggregation devices market.
Germany is expected to dominate the market in the period. Growth in platelet disorder like thrombocythemia, growing automation of platelet aggregation testing methods, and mounting acquisition and market significance for automated instruments amid diagnostic laboratories are likely to accelerate the market growth in the region. Also, growing approval for platelet treatment in cancer patients boosts the growth.
Germany follows France due to the increasingly growing number of hospitals drawing a substantial patient population. Developed healthcare infrastructure and accessibility of expert technicians are the factors fueling the growth in the market. The robust appearance of device manufacturers and many patients undergoing heart-related surgeries are bolstering the market in this region.
Promising Companies leading the Europe Platelet Aggregation Devices Market are Accriva Diagnostics, Helena Laboratories Corporation, BioData Corporation, Haemonetics Corporation, Siemens AG, Sysmex Corporation, Sentinel CH. S.p.A., Tem Group, and Aggredyne, Inc.